Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients
Suman Nag, Sampath K. Gollapudi, Carlos del Río, et al.
Science Advances (2023) Vol. 9, Iss. 30
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy
James A. Spudich, Neha Nandwani, Julien Robert‐Paganin, et al.
The EMBO Journal (2024) Vol. 43, Iss. 19, pp. 4139-4155
Closed Access | Times Cited: 7
Functional control of myosin motors in the cardiac cycle
Malcolm Irving
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 5
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Milind Y. Desai, S.E. Nissen, Theodore P. Abraham, et al.
JACC Heart Failure (2025) Vol. 13, Iss. 2, pp. 358-370
Open Access
Thick-Filament-Based Regulation and the Determinants of Force Generation
Vivek Jani, Weikang Ma
Biomedicines (2025) Vol. 13, Iss. 3, pp. 703-703
Open Access
Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions
Weikang Ma, Carlos del Río, Lin Qi, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 8
Closed Access | Times Cited: 4
Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies
R. John Solaro, Paul H. Goldspink, Beata M. Wolska
Biomedicines (2024) Vol. 12, Iss. 5, pp. 999-999
Open Access | Times Cited: 4
Mavacamten inhibits myosin activity by stabilising the myosin interacting-heads motif and stalling motor force generation
Sean N. McMillan, Judy Pitts, Bipasha Barua, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy
Joo Hee Jeong, Hwa Jung Kim, Sung Ho Hwang, et al.
Heart (2025), pp. heartjnl-325218
Closed Access
Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association
Sadiya S. Khan, Khadijah Breathett, Lynne T. Braun, et al.
Circulation (2025)
Closed Access
Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies
R. John Solaro, Paul H. Goldspink, Beata M. Wolska
(2024)
Open Access | Times Cited: 3
Genetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review
Antônio da Silva Menezes, Ana Luísa Guedes de França e Silva, Henrique Lima de Oliveira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5855-5855
Open Access | Times Cited: 3
Myosin-Catalyzed ATP Hydrolysis in the Presence of Disease-Causing Mutations: Mavacamten as a Way to Repair Mechanism
Ananya Chakraborti, Jil C. Tardiff, Steven D. Schwartz
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 19, pp. 4716-4727
Closed Access | Times Cited: 2
Myosin in autoinhibitedoffstate(s), stabilized by mavacamten, can be recruited via inotropic effectors
Weikang Ma, Carlos del Río, Lin Qi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy
Laura Sen-Martín, Ángel Fernández‐Trasancos, Miguel A. López‐Unzu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
SMYD1-mediated Mono-Methylation of Lysine K35 of the sarcomeric Myosin Heavy Chain (MHC) is fundamental for thick filament assembly in zebrafish and human iPSC-derived cardiomyocytes
Federica Diofano, Chidinma Amadi, Bernd M. Gahr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Deconvolution of polygenic risk score in single cells unravels cellular and molecular heterogeneity of complex human diseases
Sai Zhang, Hantao Shu, Jingtian Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mavacamten in hypertrophic obstructive cardiomyopathy: Prospects for AI integration and mitigating healthcare disparities
Samia Aziz Sulaiman, A. Saeed, A. Khatib, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 11, pp. 102786-102786
Closed Access | Times Cited: 1
Clinical Effect of the Modified Morrow Septal Myectomy Procedure for Biventricular Hypertrophic Cardiomyopathy
Tong Tan, Wei Zhu, Jianrui Ma, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 1, pp. 21-21
Open Access
Outcomes of a Multidisciplinary Approach to Management of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Hanna Jensen, Zaid Yousif, Trina Huynh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An overview of the treatments for hypertrophic cardiomyopathy
Wenna Xu, Fuyu Zhu, Yue Zhang, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
A Dynamic Model of Multi-state LVAD Based on LSTM Neural Network
Aiping Tan, Ying Mu, Wenqian Yu, et al.
Lecture notes in computer science (2024), pp. 203-214
Closed Access
Modelling Events in Biomedical Decision Support Systems Using Ontologies
Marko Miletic, Murat Sariyar
Studies in health technology and informatics (2024)
Open Access
Riding the Waves of Novel Therapies in Hypertrophic Cardiomyopathy
Melissa A. Austin, Alejandro de Feria, Nosheen Reza, et al.
JACC Case Reports (2024) Vol. 29, Iss. 19, pp. 102585-102585
Open Access
Mavacamten, a first-in-class cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy
Qiushi Chen, Yun Long, Mengfei Wang, et al.
Elsevier eBooks (2024), pp. 485-513
Closed Access
Load‐dependence of the activation of myosin filaments in heart muscle
Yanhong Wang, Luca Fusi, Jesús G. Ovejero, et al.
The Journal of Physiology (2024)
Open Access
Page 1 - Next Page

Scroll to top